Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 1161-1167

  Aouali, Nassera ^a   El Btaouri, Hassan ^b   Dumontet, Charles ^c   Eddabra, Lahcen ^b   Malagarie Cazenave, Sophie ^d,e   Madoulet, Claudie ^b   Morjani, Hamid ^b  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c INSERM   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Lactosylceramide; Multidrug resistance; P glycoprotein; Resistance to PSC833

Indexed keywords

CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; LACTOSYLCERAMIDE; MULTIDRUG RESISTANCE PROTEIN 1; SPHINGOLIPID; VALSPODAR; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DRUG ACCUMULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SARCOMA CELL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD; BLOTTING, WESTERN; CELL PROLIFERATION; CYCLOSPORINS; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; LACTOSYLCERAMIDES; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; TUMOR CELLS, CULTURED;

EID: 79952223525     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1180     Document Type: Article

References (32)

1. Gottesman MM and Ling V: The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580: 998-1009, 2006. (Pubitemid 43185280)
2. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993. (Pubitemid 23237876)
3. Friche E, Danks MK, Schmidt CA and Beck WT: Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res 51: 4213-4218, 1991.
4. Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, Stewart L and Redinbo MR: Mechanisms of camptothecin resistance by human topoisomerase I mutations. J Mol Biol 339: 773-784, 2004. (Pubitemid 38686344)
5. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992. (Pubitemid 23012438)
6. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG and Keppler D: The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810, 1994. (Pubitemid 24354499)
7. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F and Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537-3547, 1997. (Pubitemid 27355505)
8. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK and Ross DD: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15665-15670, 1998. (Pubitemid 29018757)
9. Ozben T: Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580: 2903-2909, 2006.
10. Lavie Y, Cao H, Bursten SL, Giuliano AE and Cabot MC: Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271: 19530-19536, 1996. (Pubitemid 26271630)
11. Morjani H, Aouali N, Belhoussine R, Veldman RJ, Levade T and Manfait M: Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. Int J Cancer 94: 157-165, 2001. (Pubitemid 32911407)
12. Kok JW, Veldman RJ, Klappe K, Koning H, Filipeanu CM and Muller M: Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. Int J Cancer 87: 172-178, 2000. (Pubitemid 30434341)
13. Lavie Y, Cao H, Volner A, Lucci A, Han TY, Geffen V, Giuliano AE and Cabot MC: Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 272: 1682-1687, 1997. (Pubitemid 27043253)
14. Liu YY, Han TY, Giuliano AE and Cabot MC: Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274: 1140-1146, 1999.
15. Veldman RJ, Klappe K, Hinrichs J, Hummel I, van der Schaaf G, Sietsma H and Kok JW: Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J 16: 1111-1113, 2002.
16. Gouaze V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, Gottesman MM, Bitterman A, Giuliano AE and Cabot MC: Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 3: 633-639, 2004. (Pubitemid 39193742)
17. Gouaze V, Liu YY, Prickett CS, Yu JY, Giuliano AE and Cabot MC: Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res 65: 3861-3867, 2005. (Pubitemid 40616367)
18. Harker WG and Sikic BI: Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 45: 4091-4096, 1985. (Pubitemid 16224856)
19. Lossos IS, Czerwinski DK, Wechser MA and Levy R: Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17: 789-795, 2003. (Pubitemid 36519378)
20. Ginzinger DG: Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30: 503-512, 2002.
21. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988. (Pubitemid 18056527)
22. Gigli M, Doglia SM, Millot JM, Valentini L and Manfait M: Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry. Biochim Biophys Acta 950: 13-20, 1988.
23. Beketic-Oreskovic L, Duran GE, Chen G, Dumontet C and Sikic BI: Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst 87: 1593-1602, 1995.
24. Leray C, Pelletier X, Hemmendinger S and Cazenave JP: Thin-layer chromatography of human platelet phospholipids with fatty acid analysis. J Chromatogr 420: 411-416, 1987. (Pubitemid 17144333)
25. Aouali N, Eddabra L, Macadre J and Morjani H: Immunosuppressors and reversion of multidrug-resistance. Crit Rev Oncol Hematol 56: 61-70, 2005.
26. Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C and Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem 272: 5974-5982, 1997. (Pubitemid 27102435)
27. Plo I, Lehne G, Beckstrom KJ, Maestre N, Bettaieb A, Laurent G and Lautier D: Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells. Mol Pharmacol 62: 304-312, 2002. (Pubitemid 34804110)
28. Degroote S, Wolthoorn J and van Meer G: The cell biology of glycosphingolipids. Semin Cell Dev Biol 15: 375-387, 2004.
29. Sprong H, van der Sluijs P and van Meer G: How proteins move lipids and lipids move proteins. Nat Rev Mol Cell Biol 2: 504-513, 2001.
30. Hinrichs JW, Klappe K, Hummel I and Kok JW: ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J Biol Chem 279: 5734-5738, 2004. (Pubitemid 38220603)
31. Klappe K, Hinrichs JW, Kroesen BJ, Sietsma H and Kok JW: MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. Int J Cancer 110: 511-522, 2004. (Pubitemid 38658016)
32. Parkin ET, Turner AJ and Hooper NM: Differential effects of glycosphingolipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase. Biochem J 358: 209-216, 2001. (Pubitemid 32778115)